A Protective Effect of Endomorphins on the Oxidative Injury of Islet

Abstract

The antioxidative capacity of endomorphins (EMs), endogenous μ-opioid receptor agonists, has been demonstrated by in vivo assays. In this study, we attempt to evaluate the effects of endomorphin 1 (EM1) and endomorphin 2 (EM2) on pancreatic islet injuries induced by streptozotocin (STZ), alloxan (ALX) and H₂O₂, respectively. Wistar rats’ islets were isolated and purified. The function of the islet cells, the insulin response to glucose stimulation was examined by insulin Radio Immuno Assay and the cell viability was measured by MTT assay. DNA fragments were performed to evaluate the apoptosis, while the cell cycle distribution was analyzed by PI staining flow cytometric analysis. Furthermore, the islet were treated with EM1, EM2 or ALX for 24 h, and the expression of p53 and p21 protein were determined by Western blot. The results showed that STZ, ALX, and H₂O₂ displayed clear concentration-dependent inhibitory effects on the pancreatic islet cells. While EMs improved the viability of islet induced by STZ, ALX or H₂O₂, and EMs enhanced insulin accumulation of the cell supernatant after ALX and STZ stimulation. Our data also showed both that EMs inhibited cell apoptosis and cell cycle G1 arrest induced by STZ and ALX through down-regulaing p53 and p21 expression. Taken together, these results demonstrate that EMs can protect islet cells from STZ, ALX and H₂O₂ induced injuries. Our observations imply that the endomorphins may have protective effects on islet cells oxidative injury.

Key words

endomorphins - pancreatic islets - oxidative damage - apoptosis

References

• 1 Mohamed AK, Bierhaus A, Schiekofer S. et al . The role of oxidative stress and NF-kappaB activation in late diabetic complications.  Biofactors. 1999;  10 157-167
• 2 Rattan R, Nayak D. High levels of plasma malondialdehyde, protein carbonyl, and fibrinogen have prognostic potential to predict poor outcomes in patients with diabetic foot wounds: a preliminary communication.  Int J Low Extrem Wounds. 2008;  7 198-203
• 3 Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass.  Physiol Rev. 2005;  85 1255-1270
• 4 Barry U, Zuo Z. Opioids: old drugs for potential new applications.  Curr Pharm Des. 2005;  11 1343-1350
• 5 Peart JN, Gross GJ. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways.  Am J Physiol Heart Circ Physiol. 2006;  291 H1746-H1753
• 6 Zadina JE, Hackler L, Ge LJ. et al . A potent and selective endogenous agonist for the mu-opiate receptor.  Nature. 1997;  386 499-502
• 7 Stone LS, Fairbanks CA, Laughlin TM. et al . Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.  Neuroreport. 1997;  8 3131-3135
• 8 Tseng LF, Narita M, Suganuma C. et al . Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.  J Pharmacol Exp Ther. 2000;  292 576-583
• 9 Jessop DS, Richards LJ, Harbuz MS. Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation.  Ann N Y Acad Sci. 2002;  966 456-463
• 10 Lin X, Yang DJ, Cai WQ. et al . Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage.  Biochim Biophys Acta. 2003;  1639 195-202
• 11 Lin X, Xue LY, Wang R. et al . Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation.  FEBS J. 2006;  273 1275-1284
• 12 SailajaDevi MM, Suresh Y. Das Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin.  J Pineal Res. 2000;  29 108-115
• 13 Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children.  Diabetes Care. 2000;  23 1389-1394
• 14 Aruna RV, Ramesh B, Kartha VN. Effect of betacarotene on protein glycosylation in alloxan induced diabetic rats.  Indian J Exp Biol. 1999;  37 399-401
• 15 Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.  FASEB J. 1999;  13 1845-1854
• 16 Downing R, Heald KA, Jay TR. Porcine islet isolation: prospective comparison of automated and manual methods of pancreatic collagenase digestion.  Br J Surg. 1993;  80 1215
• 17 Toso C, Brandhorst D, Oberholzer J. et al . Isolation of adult porcine islets of Langerhans.  Cell Transplant. 2000;  9 297-305
• 18 Portha B, Lacraz G, Kergoat M. et al . The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?.  Mol Cell Endocrinol. 2009;  297 73-85
• 19 Tanaka Y, Tran PO, Harmon J. et al . A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity.  Proc Natl Acad Sci USA. 2002;  99 12363-12368
• 20 Bonnefont-Rousselot D, Bastard JP, Jaudon MC. et al . Consequences of the diabetic status on the oxidant/antioxidant balance.  Diabetes Metab. 2000;  26 163-176
• 21 Wang CL, Wang X, Yu Y. et al . Type 1 diabetes attenuates the modulatory effects of endomorphins on mouse colonic motility.  Neuropeptides. 2008;  42 69-77
• 22 Del Guerra S, Lupi R, Marselli L. et al . Functional and molecular defects of pancreatic islets in human type 2 diabetes.  Diabetes. 2005;  54 727-735
• 23 Marchetti P, Del Guerra S, Marselli L. et al . Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.  J Clin Endocrinol Metab. 2004;  89 5535-5541
• 24 Wu HE, Mizoguchi H, Terashvili M. et al . Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.  J Pharmacol Exp Ther. 2002;  303 867-873
• 25 Irnaten M, Aicher SA, Wang J. et al . Mu-opioid receptors are located postsynaptically and endomorphin-1 inhibits voltage-gated calcium currents in premotor cardiac parasympathetic neurons in the rat nucleus ambiguus.  Neuroscience. 2003;  116 573-582
• 26 Mizoguchi H, Narita M, Wu H. et al . Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.  Neuroscience. 2000;  100 835-839
• 27 Yu Y, Wang X, Cui Y. et al . Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats.  Peptides. 2006;  27 2770-2777
• 28 Verspohl EJ, Berger U, Ammon HP. The significance of mu- and delta-receptors in rat pancreatic islets for the opioid-mediated insulin release.  Biochim Biophys Acta. 1986;  888 217-224
• 29 Garcia-Barrado MJ, Iglesias-Osma MC, Rodriguez R. et al . Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues.  Eur J Pharmacol. 2002;  448 95-104
• 30 Khawaja XZ, Green IC, Thorpe JR. et al . The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.  Biochem J. 1990;  267 233-240
• 31 Kim HY, Kim K. Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells.  J Agric Food Chem. 2007;  55 2816-2823
• 32 Kim WH, Lee JW, Gao B. et al . Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway.  Cell Signal. 2005;  17 1516-1532
• 33 Halevy O, Novitch BG, Spicer DB. et al . Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.  Science. 1995;  267 1018-1021
• 34 Kaneto H, Kajimoto Y, Fujitani Y. et al . Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction.  Diabetologia. 1999;  42 1093-1097

Correspondence